GenoScreen
August 14-19, 2022
18th International Symposium on Microbial Ecology (ISME), Lausanne - Switzerland
Meet us at the 18th International Symposium on Microbial Ecology (ISME), from August 14 to 19, 2022 in Lausanne - Switzerland.
June 26-29, 2022
Annual Meeting of the European Society of Mycobacteriology
Meet us at the 42nd Annual Meeting of the European Society of Mycobacteriology (ESM), from June 26 to 29, 2022 in Bologna - Italy.
June 10, 2022
Annual Meeting of the French Helicobacter Study Group
Meet us at the 29th Annual Meeting of the French Helicobacter Study Group (GEFH), on June 10, 2022 in Paris - France.
More information (in french)
March 10, 2022
Adebiotech Webinar "Applications of High Throughput Sequencing"
Meet us at the Adebiotech Webinar "Applications of High Throughput Sequencing" on March 10, 2022.
More information (french)
From Nov. 30 to Dec. 2, 2021
Food Ingredients Europe 2021, Frankfurt - Germany
Meet us at the "Food Ingredients Europe" conference in Frankfurt from November 30th to December 2nd 2021.
We will welcome you on our booth N°31H94
April 23-26, 2022
ECCMID 2022, Lisbon - Portugal
Find us at the 32nd European Congress of Clinical Microbiology and Infectious Diseases, in Lisbon - Portugal, April 23-26, 2022.
From October 27 to 29, 2021
14th Congress "Yeast, Models and Tools" in Strasbourg - France
Meet us at the 14th Congress "Yeast, Models and Tools" which will take place in Strasbourg, from October 27 to 29, 2021.
Subcategories
Partners
At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.
A network of strategic partners
We actively collaborate with:
Research institutes, universities and hospitals
Competitive clusters specialized in biotechnology and healthcare
Public funding bodies
A co-development strategy
Our research projects are carried out with recognized partners in France and abroad. Together, we can :
- Co-develop innovative genomics and bioinformatics solutions
- Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
- Test and validate our technologies in a variety of environments
- Launch the implementation of concrete solutions for health, agriculture and the environment
Why collaborate with GenoScreen?
- Access to an innovative sequencing technology platform
- Access to recognized expertise in bioinformatics analysis and biomarkers
- Benefit from our ability to manage collaborative R&D projects
- Strive for health, agriculture and environment
Join our network of partners
Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.
Frequently asked questions
What kind of partners work with GenoScreen?
GenoScreen works with academic laboratories, biotech companies and clusters.
What are the benefits of these partnerships?
They help us co-develop technologies, co-finance projects and accelerate innovation.
How can I propose a partnership?
You can contact us via our contact form to discuss your project and identify a potential collaboration.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.